Publications by authors named "V M Burlakov"

Claim this Profile
Ð
Рrospective multicenter study of treatment efficacy, safety, and quality of life in a large cohort of patients with inborn errors of immunity receiving subcutaneous immunoglobulin by the rapid push method.
Asmik Avedova, Elena Deripapa, Yulia Rodina, Anna Mukhina, Elena Latysheva, Vasily Burlakov

Front Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I interferon-mediated autoinflammation in two unrelated patients due to a proximal intronic splice site variant in DNASE2.
Oskar Schnappauf, Hongying Wang, Qing Zhou, Vasily Burlakov, Anna Kozlova

Res Sq· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined therapy with IL-1 and JAK inhibitors in a patient with the gene mutation and a complex inflammatory phenotype.
Vasily Burlakov, Anna Kozlova, Dmitry Pershin, Yulia Rodina, Igor Khamin

J Allergy Clin Immunol Glob· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies.
Yulia Rodina, E Deripapa, O Shvets, A Mukhina, A Roppelt, V Burlakov

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome.
Alexandra Laberko, Vasiliy Burlakov, Sarah Maier, Mario Abinun, Roderick Skinner

J Allergy Clin Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis